e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chlamydia species as a cause of community-acquired pneumonia in Canada
Marrie T.J., Peeling R.W., Reid T., De Carolis E., the Canadian Comm...
Source:
Eur Respir J 2003; 21: 779-784
Journal Issue:
May
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marrie T.J., Peeling R.W., Reid T., De Carolis E., the Canadian Comm.... Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003; 21: 779-784
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003
Severe
Chlamydia pneumoniae
community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia
Source: Eur Respir J 2001; 17: 241-245
Year: 2001
Monitoring of
Mycoplasma pneumoniae
and
Chlamydia pneumoniae
in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections
Source: Eur Respir J 2009; 33: 360-367
Year: 2009
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
The role of Chlamydia species as a cause of community-acquired pneumonia - clinical characteristics
Source: Eur Respir J 2005; 26: Suppl. 49, 409s
Year: 2005
Clinical aspects of chlamydia pneumoniae pneumonia in adults
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004
Chlamydia pneumoniae
pneumonia and
Mycoplasma pneumoniae
pneumonia: comparison of clinical findings and CT findings
Source: Eur Respir J 2004; 24: Suppl. 48, 488s
Year: 2004
Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia
Source: Eur Respir J 2011; 37: 1522-1524
Year: 2011
Atypical pathogens and respiratory tract infections
Source: Eur Respir J 2004; 24: 171-182
Year: 2004
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Chlamydia pneumoniae
and
mycoplasma pneumoniae
seropositivities in children with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 849s
Year: 2006
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Chlamydia pneumoniae infection in asthmatic patients
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 608s
Year: 2002
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia
Source: Eur Respir J 2010; 36: 969-971
Year: 2010
Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept